Evidence map›Paper›PMID 40216705›Full record

ArticleJournal of clinical psychology in medical settings2025

Exploring the Psychometric Properties of the Spanish Version of the Life Orientation Test-Revised Among Multiple Sclerosis Patients: Insights into Optimism.

Yunier Broche-Pérez, Rodneys M Jiménez-Morales, Diego D Díaz-Guerra

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of clinical psychology in medical settings, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Yunier Broche-PérezPrisma Behavioral Center, West Palm Beach, FL, USA. yunierbroche@gmail.com.
Rodneys M Jiménez-MoralesUniversidad Internacional De La Rioja, Logroño, Spain.
Diego D Díaz-GuerraUniversidad Central "Marta Abreu" de Las Villas, Santa Clara, Cuba.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Optimism, defined as the tendency to expect positive outcomes and view challenges as manageable, plays a vital role in the lives of individuals with chronic illnesses, including multiple sclerosis. Given its potential benefits, measuring optimism through validated tools like the Life Orientation Test-Revised (LOT-R) is essential for both research and clinical practice. This study aims to validate the Spanish version of the LOT-R within a sample of MS patients, assessing its psychometric properties and exploring its potential utility in clinical settings. This study included 179 patients with Relapsing-Remitting Multiple Sclerosis (PwMS). Confirmatory factor analysis (CFA) was performed to assess the factor structure of the LOT-R. Model fits were evaluated by the χ2/df value, comparative fit index (CFI), and root mean square error of approximation (RMSEA). The LOT-R showed good psychometric characteristics in our sample of PwMS. The CFA's for both models (the two correlated factors model and the second-order factor model) yielded a good model fit. Cronbach's alpha and McDonald's omega were acceptable. Optimism was significantly correlated with quality-of-life scores, resilience, and fear of relapse scale. In general terms, the LOT-10 has satisfactory psychometric properties and is suitable for measuring dispositional optimism in Spanish-speaking patients with multiple sclerosis.

Indexed as

Multiple Sclerosis, Relapsing-RemittingOptimismPsychometricsQuality of LifeAdultFactor Analysis, StatisticalFemaleHumansMaleMiddle AgedMultiple SclerosisReproducibility of ResultsSpainMultiple sclerosisOptimismOrientation Test-RevisedQuality of lifeResilienceValidation

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.